GoldBamboo.com - Knowledge is strong medicine
  

Almonds and Pre-Diabetes - Article


  Not Signed In - Sign In / Register






Diabetes

Blood Sugar; Diabetes Mellitus; Non-Insulin Dependent Diabetes Mellitus; Type II Diabetes


Clinical Trial: Almonds and Pre-Diabetes

This study is not yet open for patient recruitment.
Verified by University of Medicine and Dentistry New Jersey December 2005

Sponsors and Collaborators: University of Medicine and Dentistry New Jersey
Almond Board of California
Information provided by: University of Medicine and Dentistry New Jersey
ClinicalTrials.gov Identifier: NCT00270985

Purpose

Study Hypothesis: Daily consumption of almonds over 16-weeks will produce a decrease in HbA1c levels in adults with pre-diabetes.

Lay Summary: Persons developing type 2 diabetes mellitus (T2DM) will typically first have a condition called pre-diabetes. Lifestyle is a major factor that determines whether pre-diabetes becomes full T2DM. Lifestyle includes dietary habits and physical activity. Many people develop T2DM because of poor dietary habits and a sedentary lifestyle. Moreover, eating a high-fat, high-sugar diet can damage the blood vessels and increase the risk of strokes and heart attacks. A person’s diet may produce substances in the blood that can interfere with the production of insulin in the pancreas. Sometimes, these changes in the insulin producing cells are serious and can eventually interfere with how the cells in the body use blood sugar, which causes T2DM. Techniques are available to measure circulating substances in the blood of persons with pre-diabetes that may be associated with the development of T2DM. Laboratory research has shown that almonds contain high levels of important compounds that may influence the onset of heart disease and T2DM. A meal plan that includes almonds daily will be given to half of the study participants and the other participants will be given a meal plan that is “nut-free”. Because of the potential to delay the onset of heart disease and T2DM in some persons with pre-diabetes, this 16-week study will collect and analyze blood samples for changes that may make the person with pre-diabetes more likely to develop heart disease and T2DM. Blood samples will be collected at weeks 0, 8 and 16 to measure compounds that may be influenced by consuming almonds daily. This study will also attempt to understand other possible causes of heart disease and T2DM in persons with pre-diabetes; particularly those that might be related to body weight and body composition. Body composition techniques using very small amounts of electrical current are available to study body fat. Body weight, waist and hip measurements, blood pressure and body composition testing will be performed at the start of the study and every 4 weeks during the study. Lastly, these other possible causes of heart disease and T2DM will be investigated to look at relationships with the substances in the blood.

Condition Intervention
Diabetes
 Behavior: Almonds in a calorie controlled diet

MedlinePlus related topics:  Diabetes

Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Prospective Study

Official Title: The Metabolic Effects of Almond Consumption in Adults With Pre-Diabetes

Further study details as provided by University of Medicine and Dentistry New Jersey:

Expected Total Enrollment:  184

Study start: January 2006

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

• Age greater than 18 years • No self-reported allergy to almonds • No history of irritable bowel disease or diverticulitis that could be exacerbated by daily almond intake • Presence of pre-diabetes according to the 2005 American Diabetes Association diagnostic guidelines (fasting blood glucose between 100 to 125 mg/dl, or, casual blood glucose ≥ 140-199 mg/dl) • BMI 20-35 kg/m2 to enhance the generalizability of the study’s findings to the population of adults with pre-diabetes • Willingness to discontinue vitamin E supplement usage while enrolled in the study.

Exclusion Criteria:

- No concurrent use of corticosteroids or immunosuppressant medications (tacrolimus, cyclosporine, sirolimus, azathioprine, 6-mercaptopurine, mycophenolate moefitil, everolimus) in light of their effect on inflammatory biomarkers • No liver disease, renal disease and/or severe dyslipidemia (TG >400mg/dl or total cholesterol (TC) >300 mg/dl)

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00270985

Michelle A Wien, DrPH      973-972-9487    wienma@umdnj.edu

New Jersey
      UMDNJ, Newark,  New Jersey,  07107,  United States
Michelle A Wien, DrPH  973-972-9487    wienma@umdnj.edu 
David Bleich, MD,  Sub-Investigator
Riva Touger-Decker, PhD, RD,  Sub-Investigator
Barbara Greenberg, PhD,  Sub-Investigator
Maya Raguwanshi, MD,  Sub-Investigator
Julie O''''Sullivan Maillet, PhD, RD,  Sub-Investigator

Study chairs or principal investigators

Michelle A Wien, DrPH, RD,  Principal Investigator,  University of Medicine and Dentistry New Jersey   

More Information

Publications that report results of this study

Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Josse AR, Wong JM, de Souza R, Emam A, Parker TL, Li TJ, Josse RG, Leiter LA, Singer W, Connelly PW. Direct comparison of dietary portfolio vs statin on C-reactive protein. Eur J Clin Nutr. 2005 Jul;59(7):851-60.

Study ID Numbers:  0120050322
Last Updated:  December 28, 2005
Record first received:  December 27, 2005
ClinicalTrials.gov Identifier:  NCT00270985
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2006-01-10


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Diabetes.

July 25, 2008



Page Updated: December 9, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Insurance Quotes | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.